Michael E Prevoznik Quest Diagnostics Inc (DGX) insider trading activity

Michael E Prevoznik is SVP & General Counsel of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 38,478 shares of DGX, which is worth approximately $5.27 Million. The most recent transaction as insider was on Nov 29, 2024, when has been sold 35,146 shares (Common Stock) at a price of $162.7 per share, resulting in proceeds of $5,718,254. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.5K

0% 3M change

0.13% 12M change

Total Value Held $5.27 Million

MICHAEL E PREVOZNIK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 29 2024	SELL Open market or private sale	$5,718,254 $162.7 p/Share	35,146 Reduced 47.74%	38,478 Common Stock
Nov 29 2024	BUY Exercise of conversion of derivative security	$3,044,697 $86.63 p/Share	35,146 Added 32.31%	73,624 Common Stock
Aug 29 2024	SELL Open market or private sale	$5,044,428 $154.97 p/Share	32,551 Reduced 45.83%	38,478 Common Stock
Aug 29 2024	BUY Exercise of conversion of derivative security	$3,118,385 $95.8 p/Share	32,551 Added 31.43%	71,029 Common Stock
Feb 29 2024	SELL Open market or private sale	$706,312 $125.88 p/Share	5,611 Reduced 12.73%	38,478 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$108,795 $126.36 p/Share	861 Reduced 1.92%	44,089 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$353,181 $125.02 p/Share	2,825 Reduced 5.91%	44,950 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	$946,276 $125.02 p/Share	7,569 Added 13.68%	47,775 Common Stock
Feb 22 2024	SELL Open market or private sale	$83,378 $126.14 p/Share	661 Reduced 1.62%	40,206 Common Stock
Feb 21 2024	SELL Payment of exercise price or tax liability	$50,883 $125.02 p/Share	407 Reduced 0.99%	40,867 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	2,935 Added 6.64%	41,274 Common Stock
Mar 07 2023	SELL Open market or private sale	$668,174 $140.55 p/Share	4,754 Reduced 10.98%	38,527 Common Stock
Mar 06 2023	SELL Payment of exercise price or tax liability	$567,930 $147.86 p/Share	3,841 Reduced 8.15%	43,281 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	$1,270,856 $147.86 p/Share	8,595 Added 15.43%	47,122 Common Stock
Mar 02 2023	SELL Open market or private sale	$82,154 $138.54 p/Share	593 Reduced 1.52%	38,527 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$45,020 $140.69 p/Share	320 Reduced 0.81%	39,120 Common Stock
Feb 24 2023	SELL Open market or private sale	$200,109 $141.42 p/Share	1,415 Reduced 3.46%	39,440 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$119,914 $147.86 p/Share	811 Reduced 2.07%	38,413 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	2,442 Added 5.64%	40,855 Common Stock
May 17 2022	SELL Open market or private sale	$7,083,042 $139.97 p/Share	50,604 Reduced 56.33%	39,224 Common Stock
May 17 2022	BUY Exercise of conversion of derivative security	$3,365,672 $66.51 p/Share	50,604 Added 36.03%	89,828 Common Stock
Mar 08 2022	SELL Open market or private sale	$842,088 $135.21 p/Share	6,228 Reduced 13.7%	39,224 Common Stock
Mar 07 2022	SELL Payment of exercise price or tax liability	$691,558 $130.09 p/Share	5,316 Reduced 10.47%	45,452 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	$1,501,759 $130.09 p/Share	11,544 Added 18.53%	50,768 Common Stock
Feb 28 2022	SELL Open market or private sale	$85,930 $130.0 p/Share	661 Reduced 1.66%	39,224 Common Stock

MEP

Michael E Prevoznik

SVP & General Counsel

Secaucus, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DGX shares.

Notify only if

Value

Insider Trading

Get notified when an Quest Diagnostics Inc insider buys or sells DGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to QUEST DIAGNOSTICS INC

Track Activities on DGX

Account